Synergen Incorporated

Contact Details: 1885 33rd Street Boulder CO 80301 United States of America Tel: 303 938 6207 Fax: 303 938 6268 Email:

Loading...

Recent Publications by Synergen Incorporated:
Phase-I-study of four different schedules of pemetrexed, gemcitabine and cisplatin in patients with locally advanced or metastatic solid tumours. This non-randomised Phase-I-study determined recommended dose (RD) and...	11th March, 2009	St Georg Hospital III, Department of Medicine, Hamburg, Germany.	Eur J Cancer. 2008 Nov;44(16):2444-52. Epub 2008 Sep 18. DOI Direct Link
Correlations of mRNA expression and in vitro chemosensitivity to enzastaurin in freshly explanted human tumor cells. PURPOSE: Enzastaurin (LY317615) is a novel serine/threonine kinase...	29th July, 2008	St. Georg Hospital, Lohmuhlenstr. 5, 20099 Hamburg, Germany.	Invest New Drugs. 2008 Jun;26(3):215-22. Epub 2007 Nov 14. DOI Direct Link
In vitro chemosensitivity of freshly explanted tumor cells to pemetrexed is correlated with target gene expression. AIM OF THE STUDY: mRNA expression of genes involved in the mechanism of...	6th November, 2007	Asklepios Klinik, St. Georg, Lohmuhlenstr. 5, 20099 Hamburg, Germany.	Invest New Drugs. 2007 Oct;25(5):417-23. Epub 2007 May 30. DOI Direct Link
Phase 1b dose escalation study of erlotinib in combination with infusional 5-Fluorouracil, leucovorin, and oxaliplatin in patients with advanced solid tumors. PURPOSE: Erlotinib (Tarceva) is a potent epidermal growth factor receptor...	25th April, 2007	Department of Medicine, Asklepios Hospital St. Georg, D-20099 Hamburg,	Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):523-31. DOI Direct Link
Translational research with pemetrexed in breast cancer. Pemetrexed (Alimta) is a novel folate antimetabolite that primarily...	4th February, 2005	AK St. Georg, Department of Medicine, Hamburg, Germany.	Oncology (Williston Park). 2004 Nov;18(13 Suppl 8):66-9.
→View more Synergen Incorporated research publications.

BioNews Results for Synergen Incorporated:
Syngenta acquires 2 seed companies in California	Research & Development:  Nov 12 2009 11:47AM Matching: synergen

Synergen Incorporated Patents:
US Patent No.	Title
5459048	DNA encoding 85kd polypeptide useful in diagnosis of Mycoplasma infections in animals
4760130	Serine protease inhibitors and methods for isolation of same
4994559	Human basic fibroblast growth factor
4997929	Purified ciliary neurotrophic factor
5026839	DNA encoding a basic fibroblast growth factor
→View more Synergen Incorporated patents.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 20 individuals from Synergen Incorporated using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 1010 times since April 2007, the link to the organisation's website has been followed 0 times

Recent Search Terms used to find this page: synergen register patient | Tarceva Folate antimetabolite | Synergen | synergen | Synergen Incorporated | synergen drug discovery | synergen 66 | synergen | synergen | synergen | .

Search for more companies in Boulder

Search for more companies in CO

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Synergen Incorporated